The national ban on the purchase of organs is one instance of the government’s encroaching intervention on trade. But data reflects that this acclaimed intervention is more of a costly imposition, leaving hundreds of thousands of Americans without access to organs. Rather than enact legislation to allow the purchase of human organs by consenting parties; the U.S. regulatory healthcare system has banned all organs from being sold. Instead, Americans rely exclusively on organ donation to fulfill the waitlist of people in need. Yet despite the initial attempt at the preclusion of market exploitation, the result of this government intervention on free market trade is a national deficit of human organs; alongside an annual waitlist of hopeful, dying recipients. Worse, a burden on taxpayers to pay the government funded dialysis for patients awaiting transplants.